ゲムシタビン塩酸塩 (JAN);
Gemcitabine hydrochloride (JAN/USP)

ゲムシタビン (サンド), ゲムシタビン (サンファーマ), ゲムシタビン (ファイザー), ゲムシタビン (ファイザー), ゲムシタビン (大鵬薬品工業), ゲムシタビン (日医工ファーマ), ゲムシタビン (日医工岐阜工場), ゲムシタビン (日本化薬), ゲムシタビン (日本化薬), ゲムシタビン (武田テバ薬品), ゲムシタビン (沢井製薬), ゲムシタビン (高田製薬)
商品一覧

GEMCITABINE (Accord Healthcare), GEMCITABINE (BluePoint Laboratories), GEMCITABINE (Hospira), GEMCITABINE (Hospira), INFUGEM (Sun Pharmaceutical Industries)

GEMCITABINE (Dr. Reddy's Laboratories Limited), GEMCITABINE (Fresenius Kabi USA), GEMCITABINE (Fresenius Kabi USA), GEMCITABINE (Fresenius Kabi USA), GEMCITABINE (Hikma Pharmaceuticals USA), GEMCITABINE (Hospira), GEMCITABINE (Hospira), GEMCITABINE HYDROCHLORIDE (Accord Healthcare), GEMCITABINE (Armas Pharmaceuticals), GEMCITABINE (Armas Pharmaceuticals), GEMCITABINE (Armas Pharmaceuticals), GEMCITABINE (Athenex Pharmaceutical Division), GEMCITABINE HYDROCHLORIDE (Gland Pharma Limited), GEMCITABINE (Meitheal Pharmaceuticals), GEMCITABINE (Meitheal Pharmaceuticals), GEMCITABINE (Mylan Institutional LLC), GEMCITABINE (NorthStar Rx LLC), GEMCITABINE (Sagent Pharmaceuticals)

C9H11F2N3O4. HCl

299.0484

299.6591

抗悪性腫瘍薬, 代謝拮抗薬

非小細胞肺癌 [DS:H00014]
膵癌 [DS:H00019]
尿路上皮癌 [DS:H00022]
乳癌 [DS:H00031]
卵巣癌 [DS:H00027]
悪性リンパ腫 [DS:H00007 H00011 H01613 H01463 H00005 H01464 H01613 H01892 H00008 H00001 H00002]

RRM1 [HSA:6240] [KO:K10807]

DDI search